Ankylosing Spondylitis
Conditions
Interventions
They will be recruited 81 patients randomized into 3 groups by envelope, in which each will be made ??up of 27 patients.
Participants will be randomly assigned in a 1: 1: 1, by one of the following gr
Group two will receive the standard pharmacological intervention more counseling section, often 1 weekly meeting and 50 minutes for 12 weeks
The group will receive three standard pharmacological more exercise intervention and counseling section, and that the recommendations of the American College of Sports Medicine, lasting 60 minutes of
2nd moment for groups 2 and 3 intervention for 12 weeks
3rd time, the second collection of data on clinical and social aspects to all participants
4th time after the second collection will be three months without intervention and the sixth month of the survey will for the third collection of data on clinical and social aspects.
Behavioural
Other
F02.784.176
G11.427.590.530.698.277
E02.779.483
Sponsors
Universidade Federal de Pernambuco
Hospital das Clínicas da Universidade Federal de Pernambuco
Eligibility
Sex/Gender
Male
Age
18 Years to 59 Years
Inclusion criteria
Inclusion criteria: Having diagnosis of ankylosing spondylitis, according to the criteria New York. Age between 18 and 59 years. Male.
Exclusion criteria
Exclusion criteria: Be diagnosed with some form of physical or mental disability. Patients on medications that alter bone metabolism , such as denosumab , teriparatide , strontium ranelate. Patients with bone fracture history in the last 6 months. Patients with metabolic bone diseases and / or diseases that alter bone metabolism , including hyperparathyroidism , chronic renal failure , metabolic acidosis and alteration of serious levels of calcium, phosphorus and magnesium. Patient presenting chronic decompensated and medical negative for physical activity.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Average decrease in minutes per day during the week of sedentary behavior, the International Physical Activity Questionnaire (IPAQ) after the period of ten weeks of intervention and three months of the end of treatment. | — |
Secondary
| Measure | Time frame |
|---|---|
| Behavior change for physical activity, a score from 1 to 5 for Behavior Change Stage instrument (EMC), identified in the third and sixth month of intervention;;Inflammatory Activity of ankylosing spondylitis, in the third month of research and 3 months after the end of treatment using score from 0 to 10 by means of Bath Activity Index (BASDAI);;Functional capacity of ankylosing spondylitis, by a score from 0 to 10 using the functional index of Bath (BASFI) after the tenth week of treatment and three months after the end of treatment;;Mobility column ankylosing spondylitis, in the tenth week of treatment and three months after the end of treatment using the scores 0 to 10, by Bath metrology index (BASMI);;Quality of life, measured after ten weeks of intervention and three months after treatment score 0-18 through the quality of life questionnaire for ankylosing spondylitis (ASQoL);;Anthropometric indicators measured by the weight in kilograms, height and body circumferences in centimeters, using equations of Jackson and Pollock (7 skinfolds), body mass index (BMI) and waist and hip ratio (WHR) , measured in the tenth week of treatment and three months after the end of treatment; | — |
Countries
Brazil
Contacts
Public ContactAlessandro;Claudia Holanda;Marques
Universidade Federal de Pernambuco;Hospital das Clínicas da Universidade Federal de Pernambuco
Outcome results
None listed